One clinical trial examining the effects of semaglutide withdrawal found that, one year after going off the drug, participants regained two-thirds of the weight they initially lost
*The FDA only evaluates foods and drugs, not supplements like these products
Regulatory note: Both BPC-157 and TB-500 are prohibited by WADA for athletic use and are not FDA-approved for human administration
Greater precision tends to produce more predictable pharmacologic effects, while variability can introduce uncertainty in both dosing and outcomes
A dose that provides meaningful weight loss or blood sugar control without intolerable side effects is the right dose, regardless of whether it matches the maximum on the chart
CrossRef Knowledge, Attitudes, and Practices of Chronic Type 2 Diabetes Patients in China Toward Continuous Glucose Monitoring: An Online Questionnaire Survey Bingling Liu, Xueyi Wu, Xiao Zou, Fei Sun, Jie Yu Diabetes, Metabolic Syndrome and Obesity.2025